WallStreetZenWallStreetZen

NASDAQ: PGNY
Progyny Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Progyny earnings were $67.7M for the trailing 12 months ending Mar 31, 2026, with 35.6% growth year over year. The latest PGNY earnings report on Mar 31, 2026 announced Q1 2026 earnings of $24.2M, up 94.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PGNY reported annual earnings of $58.5M, with 7.7% growth. The next PGNY earnings date is Aug 6, 2026.

PGNY past earnings growth

How has PGNY's earnings growth performed historically?

Company
35.59%
Industry
78.65%
Market
87.84%
PGNY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PGNY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PGNY's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PGNY earnings history

Current Revenue
$1.3B
Current Earnings
$67.7M
Current Profit Margin
5.2%

PGNY Return on Equity

Current Company
13.3%
Current Industry
-1.8%
Current Market
13.5%
PGNY's Return on Equity (13.3%)... subscribe to Premium to read more.
High Return on Equity Performance

PGNY Return on Assets

Current Company
9%
Current Industry
1.6%
PGNY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PGNY announces earnings.

PGNY Return on Capital Employed

Current Company
22.87%
Current Industry
2.9%
PGNY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PGNY vs Health Information Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PGNY$111.10M$67.69M+3.61%$0.80
OMCL$118.93M$20.43M-11.92%$0.44
WGS-$48.50M-$77.81MN/A-$2.66
HTFL-$92.89M-$111.83MN/A-$1.52
TDOC$214.66M-$171.15MN/A-$0.97
View Top Health Information Service Stocks

PGNY earnings dates

Next earnings date
Aug 6, 2026

Progyny Earnings Reports & History FAQ

What were Progyny's earnings last quarter?

On PGNY's earnings call on Invalid Date, Progyny (NASDAQ: PGNY) reported Q1 2026 earnings per share (EPS) of $0.30, up 66.67% year over year. Total PGNY earnings for the quarter were $24.23 million. In the same quarter last year, Progyny's earnings per share (EPS) was $0.18.

If you're new to stock investing, here's how to buy Progyny stock.

When does Progyny report earnings?

The next PGNY earnings date is Invalid Date. Add PGNY to your watchlist to be reminded of Progyny's next earnings date.

Is Progyny profitable or losing money?

As of the last Progyny earnings report, Progyny is currently profitable. Progyny's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $67.69 million, a 28.95% increase year over year.

What was PGNY's earnings growth in the past year?

As of Progyny's earnings date in Invalid Date, Progyny's earnings has grown 35.59% year over year. This is 43.06 percentage points lower than the US Health Information Services industry earnings growth rate of 78.65%. PGNY earnings in the past year totalled $67.69 million.

What are Progyny's earnings expectations?

The current EPS estimate for Progyny's earnings report in Invalid Date is $0.52.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.